Am. J. Respir. Crit. Care Med., Vol 155, No. 1, 01 1997, 351-357.
Prednisone increases PGH-synthase 2 in atopic humans in vivo
RT Dworski, CD Funk, JA Oates and JR Sheller
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2650, USA.
We compared the expression of prostaglandin H synthase-2 (PGHS-2,
cyclooxygenase) message and protein in alveolar macrophages (AM) and blood
monocytes (BM) from 20 atopic subjects (AS) and nine control subjects (CS)
at baseline and after 1 to 14 d of oral administration of therapeutic doses
of prednisone. At baseline, the amounts of PGHS-2 mRNA in AM and BM varied
within a similar range among subjects from each group. PGHS-2 protein was
present in AM and BM from most AS, but it was also present in CS. In AS,
PGHS-2 mRNA and protein significantly increased after prednisone
administration, whereas in CS PGHS-2 message and protein remained
undetectable or, if present at baseline, was decreased after prednisone. Ex
vivo both atopic and normal monocytes and macrophages exhibited the
expected decrease in stimulated PGHS-2 mRNA with glucocorticoids. PGHS-1
expression was not altered by prednisone in either group. The differential
regulation of the inducible PGHS isoform by prednisone may be mediated by
effects on cytokine production in AS.